Delivery Order SPE2DB25D7068-SPE2DB25FTYCC
- Not listed
- The Defense Logistics Agency awarded a $1,062.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trumenba 120 MCG/0.5 ML vaccine on August 19, 2025, with completion targeted for August 20, 2025. This non-set-aside award represents a single delivery order under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as the performance site for this pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $1,097.44 delivery order to AmerisourceBergen Drug Corp for the supply of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml units. The contract was competitively awarded without set-aside provisions and carries a firm fixed price. The award was executed on June 2, 2025, with an ultimate completion date of June 3, 2025, and performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $1,872.68 to AmerisourceBergen Drug Corp for the supply of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml units. This non-set-aside, firm fixed-price delivery order was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a procurement of pharmaceutical products supporting the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Trumenba 120 micrograms/0.5 milliliter vaccine in 0.5 milliliter units, with a ceiling value of $1,749.30 and firm fixed pricing. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is...
- This delivery order, valued at $1,264.96, was awarded to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Trumenba 120 MCG/0.5 ML vaccine in 0.5 ML quantities. The contract is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), with performance to be completed by April 25, 2025, and fulfillment at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating it was...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,125.04 for TRUMENBA 120MCG (meningococcal B vaccine) on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract, which was competitively awarded with no set-aside designation, utilizes firm fixed pricing and is being performed at the company's Conshohocken, PA facility. This delivery order falls under the Defense Logistics...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,062.52 contract is for the supply of 120 mcg/0.5 ml doses of the Trumenba vaccine, with a performance period ending on May 8, 2025. The award is not set-aside and represents an open competition. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a $1,797 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561529638 Trumenba 120 mcg/0.5 ml vaccine doses. The single day contract has a period of performance from July 18 through July 19, 2023 for product delivery to a location in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for the meningococcal vaccine Trumenba supports DLA's mission to provide...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml doses. The firm-fixed-price delivery order has a ceiling value of $2,887.80 and an ultimate completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of 120 mcg/0.5 ml doses of the TRUMENBA vaccine, a total ceiling value of $2,125.04. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTYCCDelivery Order
The Defense Logistics Agency awarded a $2,125.04 delivery order to AmerisourceBergen Drug Corp for Trumenba 120 MCG/0.5 ML vaccine on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price contract is classified as a delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle that extends through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, leverages its expansive IDC vehicle to supply diverse pharmaceutical products and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Trumenba vaccine procurement reflects the company's ongoing role in supporting military medical supply chain operations through its extensive portfolio of brand-name and generic medications, vaccines, and specialized healthcare products. The DLA Troop Support is planning next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple anticipated regional awards, positioning AmerisourceBergen as a strategic supplier within the evolving federal pharmaceutical procurement landscape.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/19/25 |